The store will not work correctly when cookies are disabled.
4,5-Dihydro-4,6-diphenyl-2H-indazol-3-ol
ID: ALA2272770
PubChem CID: 76312606
Max Phase: Preclinical
Molecular Formula: C19H16N2O
Molecular Weight: 288.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1[nH]nc2c1C(c1ccccc1)CC(c1ccccc1)=C2
Standard InChI: InChI=1S/C19H16N2O/c22-19-18-16(14-9-5-2-6-10-14)11-15(12-17(18)20-21-19)13-7-3-1-4-8-13/h1-10,12,16H,11H2,(H2,20,21,22)
Standard InChI Key: AFMNCSOQJIGRBM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
25.5676 -24.2686 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.4794 -23.4582 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.2267 -23.1238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7746 -23.7303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5917 -23.7303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0003 -24.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5917 -25.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7746 -25.1485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3660 -24.4394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.3975 -22.3254 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.0003 -25.8534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8175 -25.8534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2261 -26.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8175 -27.2716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0003 -27.2716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5917 -26.5625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0003 -23.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5917 -22.3162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0003 -21.6072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8175 -21.6072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2261 -22.3162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8175 -23.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 2 0
4 9 1 0
3 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
11 16 2 0
7 11 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
5 17 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 288.35 | Molecular Weight (Monoisotopic): 288.1263 | AlogP: 4.19 | #Rotatable Bonds: 2 |
Polar Surface Area: 48.91 | Molecular Species: ACID | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.21 | CX Basic pKa: 2.80 | CX LogP: 4.06 | CX LogD: 2.67 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: 0.07 |
References
1. Shakil NA, Singh MK, Sathiyendiran M, Kumar J, Padaria JC.. (2013) Microwave synthesis, characterization and bio-efficacy evaluation of novel chalcone based 6-carbethoxy-2-cyclohexen-1-one and 2H-indazol-3-ol derivatives., 59 [PMID:23229055] [10.1016/j.ejmech.2012.10.038] |